• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Orthofix streamlines, settles infringement suit

Orthofix streamlines, settles infringement suit

December 16, 2010 By MassDevice staff

OFIX logo

UPDATE: Dec. 17, 3:57 p.m.

Orthofix International NV (NSDQ:OFIX) is streamlining its operations, aiming to save up to $7 million a year.

The reorganization is "another key step toward the achievement of our plan to improve our operating profit margin, and was facilitated in part by the recent consolidation of operations into our new facility in Lewisville, Texas," president and CEO Alan Milinazzo said in prepared remarks. It will mean a charge of $4 million, or 13 cents per diluted share, to the company’s fourth-quarter books.

Dan Yarbrough, vice president of investor relations, told MassDevice that "probably less than half" of the employees affected by the layoffs are in the U.S. Yarbrough declined to be more specific about the layoffs.

Orthofix is also shifting a small, 10-person office from Boston to Lewisville, he added, including CEO Alan Millinazzo and CFO Robert Vaters and Yarbrough himself.

"Last summer consolidated a couple of our other business facilities, one in Mass. and one in N.J., and we folded them into an operation we already had in Dallas, and moved it all to a new building there," he told us.

Orthofix also announced the settlement of a patent infringement lawsuit filed against it by NuVasive Inc. (NSDQ:NUVA) and Osiris Therapeutics Inc. (NSDQ:OSIR) in April in the U.S. District court for New Jersey over its Trinity Evolution allograft. The settlement involves a licensing agreement for the tissue graft product that will see Orthofix log another, $2 million (or 7 cents per diluted share) charge on its Q4 books.

As a result, the company lowered its Q4 earnings outlook from 59 cents to 62 cents per share to 39 cents to 42 cents. Revenues are expected to be lower than prior forecasts as well, "primarily due to a slower growth rate in the company’s spine stimulation business." Orthofix said fourth-quarter sales of $142 million to $144 million; full-year sales are pegged at $562.6 million to $564.6 million.

OFIX shares were down 4.2 percent to $28.02 in mid-day activity Dec. 16. Shares closed at $27.26 the next day, down another 1.7 percent.

Filed Under: Business/Financial News, Legal News, News Well, Orthopedics Tagged With: Nuvasive, Orthofix, Osiris Therapeutics Inc.

More recent news

  • Aurora Spine begins first procedures with Aero lumbar fusion system
  • Caranx Medical surgical robot TaviPilot AI software wins FDA clearance
  • InspireMD launches carotid stent in U.S. after FDA approval
  • Neuros Medical raises $56M Series D to support nerve stim tech
  • CorWave reports first-in-human LVAD implant

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy